carvacrol has been researched along with Acute Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cetinkaya, A; Duzcu, SE; Ozturk, H; Tekce, BK | 1 |
| Domitrović, R; Potočnjak, I | 1 |
2 other study(ies) available for carvacrol and Acute Kidney Failure
| Article | Year |
|---|---|
Carvacrol attenuates histopathogic and functional impairments induced by bilateral renal ischemia/reperfusion in rats.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Creatinine; Cymenes; Glutathione; Kidney; Male; Malondialdehyde; Monoterpenes; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase | 2018 |
Carvacrol attenuates acute kidney injury induced by cisplatin through suppression of ERK and PI3K/Akt activation.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cisplatin; Cymenes; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Immunoenzyme Techniques; Male; Mice; Mice, Inbred BALB C; Monoterpenes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt | 2016 |